echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Five new drugs were selected as "major progress of Chinese medicine in 2019"

    Five new drugs were selected as "major progress of Chinese medicine in 2019"

    • Last Update: 2020-01-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends] on January 13, the Chinese Academy of Medical Sciences released "major progress in Chinese medicine in 2019", among which 7 achievements were selected as "major progress in pharmacy", including 5 global new drugs and 2 basic researches Li Song, academician of Chinese Academy of engineering and pharmaceutical chemist, believes that these achievements may support future drug research, especially provide new mechanisms and targets The author makes a brief inventory of the five global new drugs selected The listing of rosatasi, a new renal anemia drug, has brought a new treatment plan for renal anemia patients, which can effectively improve the symptoms of anemia In addition, before the treatment of renal anemia, injection is often needed, and rosaltas only needs to be taken orally, which is more friendly to patients According to the introduction, the technology used to develop losartan is the "principle of hypoxia inducible factor" technology which won the Nobel Prize in 2019 It is worth mentioning that rosaltas is the first class 1 innovative drug developed in China with a new mechanism However, a class of new drugs are generally highly innovative, which also proves the progress of Chinese drug innovation "Zebotinib" is understood to be a new anticancer drug, zebotinib, developed by a team of Chinese scientists in Baiji, China On November 14, 2019, the U.S FDA announced the accelerated approval of zebutini for marketing to treat adult mantle cell lymphoma patients who have received at least one treatment in the past It is worth mentioning that this is also the first new anti-cancer drug independently developed by Chinese enterprises and approved by FDA In the view of the industry, the new drug can be listed in the United States, which proves that local Chinese pharmaceutical companies have the ability to develop drugs of the same level as the United States "Ganlute sodium capsule" is a new drug for the treatment of Alzheimer's disease (AD) developed in China over 22 years It is the first drug approved for the treatment of Alzheimer's disease in the world since 2003, and the sixth drug available for clinical treatment of ad in the world It is understood that in the treatment of mild to moderate Alzheimer's disease, ganlute sodium capsule can improve the cognitive function of patients On December 29, 2019, mannose sodium capsule was officially launched However, there is a great controversy in the industry because of the lack of more clinical data on the efficacy and safety of ganlute sodium capsule But it does give patients a choice of clinical medication In June 2019, corynemycin, a new anti infective drug, was approved by the State Food and Drug Administration for the treatment of upper respiratory tract infection Clinical comparison shows that colistin not only has the characteristics of strong tissue permeability, low adverse reaction rate, anti drug resistance, anti super bacteria and other super antibiotics, but also has made a significant breakthrough in anti-inflammatory immunity, interference in tumor progress, inhibition of tumor metastasis and other aspects In addition, compared with azithromycin, coriamycin has better efficacy and safety The industry believes that the listing of the drug will be of great help to clinical application "Benwemod cream" benwemod cream is used for local treatment of mild to moderate stable psoriasis vulgaris in adults Data show that psoriasis is a common chronic inflammatory skin disease, which is recognized as a difficult problem in the international medical community Benwemod cream, a psoriasis treatment drug, was approved for marketing by the State Drug Administration in May 2019 Benwemod cream has become the first topical cream for psoriasis treatment in the world for more than 30 years It is reported that benwemod cream has better curative effect than carbotriol, which increases the choice of doctors and patients.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.